Vor Biopharma VOR Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's accrued liabilities, current?
- Vor Biopharma (VOR) reported accrued liabilities, current of $14.73M in Q1 2026.
- How has Vor Biopharma's accrued liabilities, current changed year-over-year?
- Vor Biopharma's accrued liabilities, current increased by 69.6% year-over-year, from $8.69M to $14.73M.
- What is the long-term trend for Vor Biopharma's accrued liabilities, current?
- Over 5 years (2020 to 2025), Vor Biopharma's accrued liabilities, current has grown at a 25.9% compound annual growth rate (CAGR), from $6.26M to $19.76M.